Nalaganje...
Immunotherapy for Gastroesophageal Cancer
Survival for patients with advanced oesophageal and stomach cancer is poor; together these cancers are responsible for more than a million deaths per year globally. As chemotherapy and targeted therapies such as trastuzumab and ramucirumab result in modest improvements in survival but not long-term...
Shranjeno v:
| izdano v: | J Clin Med |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5086586/ https://ncbi.nlm.nih.gov/pubmed/27669318 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm5100084 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|